{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:25Z","timestamp":1791412525770,"version":"4.3.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vulvovaginal candidiasis (VVC) is a common gynecologic problem in the United States but estimates of its true incidence and prevalence are lacking. We estimated self-reported incidence and lifetime prevalence of healthcare provider-diagnosed VVC and recurrent VVC (RVVC), assessed treatment types, and evaluated demographic and health-related risk factors associated with VVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey sent to 4548 U.S. adults; data were weighted to be representative of the population. We conducted descriptive and bivariate analyses to examine demographic characteristics and health related factors associated with having VVC in the past year, lifetime prevalence of VVC, and over-the-counter (OTC) and prescription antifungal treatment use. We conducted multivariate analyses to assess features associated with 1) having VVC in the past year, 2) number of VVC episodes in the past year, and 3) lifetime prevalence of VVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the subset of 1869 women respondents, 98 (5.2%) had VVC in the past year; of those, 5 (4.7%) had RVVC. Total, 991 (53%) women reported healthcare provider-diagnosed VVC in their lifetime. Overall, 72% of women with VVC in the past year reported prescription antifungal treatment use, 40% reported OTC antifungal treatment use, and 16% reported both. In multivariate analyses, odds of having VVC in the past year were highest for women with less than a high school education (aOR\u2009=\u20096.30, CI: 1.84\u201321.65), with a child\/children under 18\u00a0years old (aOR\u2009=\u20093.14, CI: 1.58\u20136.25), with diabetes (aOR\u2009=\u20092.93, CI: 1.32\u20136.47), who were part of a couple (aOR\u2009=\u20092.86, CI: 1.42\u20135.78), and with more visits to a healthcare provider for any reason (aOR\u2009=\u20092.72, CI: 1.84\u20134.01). Similar factors were associated with increasing number of VVC episodes in the past year and with lifetime prevalence of VVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VVC remains a common infection in the United States. Our analysis supports known clinical risk factors for VVC and suggests that antifungal treatment use is high, underscoring the need to ensure appropriate diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-022-01741-x","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T08:06:48Z","timestamp":1652170008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020"],"prefix":"10.1186","volume":"22","author":[{"given":"Kaitlin","family":"Benedict","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson L.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle Angelique M.","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"1741_CR1","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Vaginitis in nonpregnant patients. ACOG practice bulletin summary, number 215. Obstet Gynecol. 2020;135(1):243\u20135.","DOI":"10.1097\/AOG.0000000000003605"},{"key":"1741_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/cid\/ciaa260","volume":"72","author":"SL Hillier","year":"2020","unstructured":"Hillier SL, Austin M, Macio I, Meyn LA, Badway D, Beigi R. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis. 2020;72:1538\u201343.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1741_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jof6010027","volume":"6","author":"HME Willems","year":"2020","unstructured":"Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi (Basel). 2020;6(1):27.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"1741_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","volume":"214","author":"JD Sobel","year":"2016","unstructured":"Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15\u201321.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1741_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6874-14-43","volume":"14","author":"SD Rathod","year":"2014","unstructured":"Rathod SD, Buffler PA. Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. BMC Womens Health. 2014;14(1):43.","journal-title":"BMC Womens Health"},{"issue":"11","key":"1741_CR6","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"1741_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.annepidem.2017.08.010","volume":"27","author":"F Blostein","year":"2017","unstructured":"Blostein F, Levin-Sparenberg E, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol. 2017;27(9):575-82.e3.","journal-title":"Ann Epidemiol"},{"key":"1741_CR8","unstructured":"United States Census Bureau. Annual estimates of the resident population for selected age groups by sex for the United States: April 1, 2010 to July 1, 2019. Available from: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2010s-national-detail.html"},{"issue":"11","key":"1741_CR9","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/cid\/ciy776","volume":"68","author":"K Benedict","year":"2019","unstructured":"Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68(11):1791\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1741_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/jwh.1998.7.1167","volume":"7","author":"B Foxman","year":"1998","unstructured":"Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Womens Health. 1998;7(9):1167\u201374.","journal-title":"J Womens Health"},{"key":"1741_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1477-7525-11-169","volume":"11","author":"S Aball\u00e9a","year":"2013","unstructured":"Aball\u00e9a S, Guelfucci F, Wagner J, Khemiri A, Dietz J-P, Sobel J, et al. Subjective health status and health-related quality of life among women with recurrent vulvovaginal candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11:169.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1741_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/LGT.0b013e318273e8cf","volume":"17","author":"B Foxman","year":"2013","unstructured":"Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340\u20135.","journal-title":"J Low Genit Tract Dis"},{"key":"1741_CR13","doi-asserted-by":"crossref","unstructured":"Bullarbo M, Andersch B, Samuelson E, Lindgren \u00c5, Kondori N, Mattsby-Baltzer I. Self-diagnosis of vulvovaginal candidiasis is poor: a comparison of diagnostic methods introducing \u03b2-Glucan as a complement. Reproduct Syst Sex Disord Curr Res. 2017;6.","DOI":"10.4172\/2161-038X.1000202"},{"issue":"2","key":"1741_CR14","first-page":"e13407","volume":"13","author":"L Mohammed","year":"2021","unstructured":"Mohammed L, Jha G, Malasevskaia I, Goud HK, Hassan A. The interplay between sugar and yeast infections: do diabetics have a greater predisposition to develop oral and vulvovaginal candidiasis? Cureus. 2021;13(2):e13407.","journal-title":"Cureus"},{"issue":"4","key":"1741_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007435-200004000-00009","volume":"27","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, D\u2019Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27(4):230\u20135.","journal-title":"Sex Transm Dis"},{"key":"1741_CR16","unstructured":"Tsay S, Bartoces M, Vallabhaneni S, Jackson BR, Hicks L. Antifungal prescribing patterns in the outpatient setting\u2014United States, 2015. In: The Society for Healthcare Epidemiology of America Spring 2018 conference; April 18\u201320, Portland, Oregon2018."},{"key":"1741_CR17","unstructured":"CDC. Sexually Transmitted Disease Surveillance 2019. Atlanta: U.S. Department of Health and Human Services. 2021."},{"issue":"3","key":"1741_CR18","first-page":"370","volume":"70","author":"LM King","year":"2020","unstructured":"King LM, Bartoces M, Fleming-Dutra KE, Roberts RM, Hicks LA. Changes in US Outpatient Antibiotic Prescriptions From 2011\u20132016. Clin Infect Dis. 2020;70(3):370\u20137.","journal-title":"Clin Infect Dis"},{"key":"1741_CR19","doi-asserted-by":"crossref","unstructured":"CDC. Vulvovaginal Candidiasis 2015 Available from: https:\/\/www.cdc.gov\/std\/tg2015\/candidiasis.htm.","DOI":"10.12968\/indn.2015.3.35"},{"issue":"4","key":"1741_CR20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2015","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases Society of America. Clin Infect Dis. 2015;62(4):e1\u201350.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1741_CR21","first-page":"419","volume":"99","author":"DG Ferris","year":"2002","unstructured":"Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002;99(3):419\u201325.","journal-title":"Obstet Gynecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01741-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T08:11:13Z","timestamp":1652170273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01741-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1741"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01741-x","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Methods were carried out in accordance with relevant guidelines and regulations. CDC licensed this data from Porter Novelli. While Porter Novelli and Ipsos are not subject to CDC Institutional Board review, they do adhere to all professional standards and codes of conduct set forth by the ESOMAR Code of Conduct (\n                      \n                      ) and the Insights Association (\n                      \n                      ). Respondents were informed that their answers were being used for market research and they may refuse to answer any question at any time. No personal identifiers were included in the data file provided to CDC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"147"}}